With support from the European Union, WHO Europe has co‑created Long COVID myth-busters with patients and experts, pairing harmful myths with real stories.

There are no approved treatments for post-COVID-19 condition, a debilitating disease state following SARS-CoV-2 infection that is estimated to affect tens of millions of people.

After surviving Coronavirus Disease 2019 (COVID-19), some people develop symptoms known as post-acute sequelae of COVID-19 (PASC). PASC is an emerging phenomenon yet to be fully understood, and identifying risk factors has been challenging.

A substantial proportion of patients suffer from Post-COVID Syndrome (PCS) with fatigue and impairment of memory and concentration being the most important symptoms.

Some children and young people (CYP) infected with SARS-COV-2 experience impairing symptoms post-infection, known as post-COVID-19 condition (PCC).

Patients suffering from post-COVID syndrome generally feel supported by their general practitioners; they take their complaints seriously and actively collaborate on finding solutions.

By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for Europe.

The recent global COVID-19 pandemic has had a profound and enduring impact, resulting in substantial loss of life.